Basit öğe kaydını göster

dc.contributor.authorOzakbas, Serkan
dc.contributor.authorTurkoglu, Recai
dc.contributor.authorTamam, Yusuf
dc.contributor.authorTerzi, Murat
dc.contributor.authorTaskapilioglu, Ozlem
dc.contributor.authorYucesan, Canan
dc.contributor.authorTurkes, Nevin
dc.date.accessioned2020-06-21T13:11:13Z
dc.date.available2020-06-21T13:11:13Z
dc.date.issued2018
dc.identifier.issn2211-0348
dc.identifier.issn2211-0356
dc.identifier.urihttps://doi.org/10.1016/j.msard.2018.03.009
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11646
dc.descriptionTASKAPILIOGLU, OZLEM/0000-0003-4436-3797; Turkoglu, Recai/0000-0001-9724-851X; Yigit, Pinar/0000-0002-1461-069X; Limoncu, Hatice/0000-0002-8146-4493en_US
dc.descriptionWOS: 000433294800016en_US
dc.descriptionPubMed: 29605801en_US
dc.description.abstractBackground: Cognitive impairment (CI) is a common problem in multiple sclerosis (MS), may occur either in early or late phase of the disease, and impairs quality of life. Objectives: This study aimed to determine the prevalence of CI and related risk factors in relapsing-remitting MS (RRMS) patients in Turkey. Methods: The present cross-sectional, multi-center, and nationally representative study included RRMS patients. Sociodemographic characteristics, cognitive functions and additional outcomes were compared between patients with and without CI. Results: The analyses included 487 RRMS patients. According to the BRB-N battery results, CI prevalence was 53.7%. There was a negative significant correlation of BRB-N subtests with age, disease duration, and EDSS and MSNQ-patient rated scores. On the logistic regression analysis, increased age, living in village/rural area, high income level, and high EDSS score were significant increasing risk factors in the development of CI. Conclusions: This is the first national cognitive data obtained from MS in Turkey, which is a country between Europe and Asia and thus has characteristics of both continents. The similarity of the results of the present study obtained from Turkey to the Western-based data indicates that CI is universal in MS and the main factors affecting CI have not changed.en_US
dc.description.sponsorshipMS Research Associationen_US
dc.description.sponsorshipThe study was funded by MS Research Association.en_US
dc.language.isoengen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.isversionof10.1016/j.msard.2018.03.009en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMultiple sclerosisen_US
dc.subjectCognitionen_US
dc.subjectPrognosisen_US
dc.subjectPrevalenceen_US
dc.titlePrevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trialen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume22en_US
dc.identifier.startpage70en_US
dc.identifier.endpage76en_US
dc.relation.journalMultiple Sclerosis and Related Disordersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster